Gebbink MF - Search Results

1

Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope.

de Laat B, van Berkel M, Urbanus RT, Siregar B, de Groot PG, Gebbink MF, Maas C. de Laat B, et al. Among authors: gebbink mf. Arthritis Rheum. 2011 Dec;63(12):3960-8. doi: 10.1002/art.30633. Arthritis Rheum. 2011. PMID: 21898342 Free article.

2

A role for protein misfolding in immunogenicity of biopharmaceuticals.

Maas C, Hermeling S, Bouma B, Jiskoot W, Gebbink MF. Maas C, et al. Among authors: gebbink mf. J Biol Chem. 2007 Jan 26;282(4):2229-36. doi: 10.1074/jbc.M605984200. Epub 2006 Nov 29. J Biol Chem. 2007. PMID: 17135263 Free article.

3

Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Maas C, Govers-Riemslag JW, Bouma B, Schiks B, Hazenberg BP, Lokhorst HM, Hammarström P, ten Cate H, de Groot PG, Bouma BN, Gebbink MF. Maas C, et al. Among authors: gebbink mf. J Clin Invest. 2008 Sep;118(9):3208-18. doi: 10.1172/JCI35424. J Clin Invest. 2008. PMID: 18725990 Free PMC article.

4

Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.

Hermeling S, Schellekens H, Maas C, Gebbink MF, Crommelin DJ, Jiskoot W. Hermeling S, et al. Among authors: gebbink mf. J Pharm Sci. 2006 May;95(5):1084-96. doi: 10.1002/jps.20599. J Pharm Sci. 2006. PMID: 16552750

5

Glycation induces formation of amyloid cross-beta structure in albumin.

Bouma B, Kroon-Batenburg LM, Wu YP, Brünjes B, Posthuma G, Kranenburg O, de Groot PG, Voest EE, Gebbink MF. Bouma B, et al. Among authors: gebbink mf. J Biol Chem. 2003 Oct 24;278(43):41810-9. doi: 10.1074/jbc.M303925200. Epub 2003 Aug 8. J Biol Chem. 2003. PMID: 12909637 Free article.

6

Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin.

Wu YP, Bloemendal HJ, Voest EE, Logtenberg T, de Groot PG, Gebbink MF, de Boer HC. Wu YP, et al. Among authors: gebbink mf. Blood. 2004 Aug 15;104(4):1034-41. doi: 10.1182/blood-2003-12-4293. Epub 2004 Apr 6. Blood. 2004. PMID: 15069014 Free article.

7

Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs.

Maas C, Schiks B, Strangi RD, Hackeng TM, Bouma BN, Gebbink MF, Bouma B. Maas C, et al. Among authors: gebbink mf. Amyloid. 2008 Sep;15(3):166-80. doi: 10.1080/13506120802193498. Amyloid. 2008. PMID: 18925455

8

Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.

Bouma B, Maas C, Hazenberg BP, Lokhorst HM, Gebbink MF. Bouma B, et al. Among authors: gebbink mf. J Thromb Haemost. 2007 Jun;5(6):1139-42. doi: 10.1111/j.1538-7836.2007.02457.x. Epub 2007 Feb 20. J Thromb Haemost. 2007. PMID: 17371485 Free article. No abstract available.

9

Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).

Gebbink MF, Bouma B, Maas C, Bouma BN. Gebbink MF, et al. FEBS Lett. 2009 Aug 20;583(16):2691-9. doi: 10.1016/j.febslet.2009.06.013. Epub 2009 Jun 13. FEBS Lett. 2009. PMID: 19527723 Free article. Review.

10

Molecular and cellular aspects of protein misfolding and disease.

Herczenik E, Gebbink MF. Herczenik E, et al. Among authors: gebbink mf. FASEB J. 2008 Jul;22(7):2115-33. doi: 10.1096/fj.07-099671. Epub 2008 Feb 26. FASEB J. 2008. PMID: 18303094 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters